top of page

CELLTIUM is redefining Personalized Biotechnology

PRECISION™ Therapeutics: Innovative Scientific Advances

icons8-neuron-64 (2).png

At CELLTIUM, we are driven to excel in the field of biotechnology by developing groundbreaking, first-in-class curative therapies. Our focus encompasses a range of critical neurological disorders, including Charcot-Marie-Tooth disease (CMT), diabetic peripheral neuropathy (DPN), chemotherapy-induced peripheral neuropathy (CIPN), and amyotrophic lateral sclerosis (ALS). Our mission is to transform treatment paradigms in these areas, setting new benchmarks in biotechnological healthcare solutions.


CELLTIUM is seeking for research talent as well as highly-motivated management. Let us know about your brilliant urge to make a real difference.

CELLTIUM is partnering with leading capitalists to further biotech innovations for healthier humanity.

DAEKYO Daekyo Investment.png
SL Invenuki.png
Korea University Technology Holding Nuki.png
JB Lucky.png
Korea Venture Investment Lucky.png
Shinhan Lucky.png
bottom of page